The McEwen Stem Cell Institute was established in December 2018 with a mission to develop new stem cell-based therapies for chronic diseases with limited therapeutic options. Formerly the McEwen Centre for Regenerative Medicine, the McEwen Institute has been a recognized leader in stem cell research and regenerative medicine since 2007, and is home to researchers with extensive experience in stem cell and human developmental biology.
Our team of five appointed investigators is developing cell-based therapies in four major disease areas — heart disease, liver disease, diabetes and blood cell disorders. Our research programs are organized around the following four organ-specific programs:
· Heart – exploring how to restore function in damaged hearts and make electronic pacemakers obsolete
· Liver – exploring how to treat liver disease
· Pancreas – studying how to eliminate insulin injections to manage diabetes
· Blood – exploring how to beat diseases of the blood system
We collaborate with UHN researchers and clinicians, as well as with biotechnology and pharmaceutical companies to develop innovative cell-based therapies and to advance these therapies to the clinic.
For more information, see the main McEwen Stem Cell Institute website.
The McEwen Stem Cell Institute (McEwen) is a newly established research institute at UHN that will focus on developing novel stem cell-based therapies to treat diseases with current unmet clinical need. The institute will be built by recruiting Scientists with expertise in human stem cell biology and genome engineering, dedicated to translating research in basic science to new therapeutic applications. McEwen will function in partnership with UHN clinical and research programs, as well as biotechnology and pharmaceutical companies to achieve these goals.
The McEwen will focus initially on four disease programs:
- Heart
- Diabetes
- Liver
- Blood
